A linchpin carbacyclization approach for the synthesis of carbanucleosides

Journal of Organic Chemistry

Volumn 73, Issue 23, 2008, Pages 9197-9206

  Leung, Leo M H ^a   Gibson, Vicky ^b   Linclau, Bruno ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Carbosynth Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL REACTIONS; STEREOCHEMISTRY;

CHEMICAL EQUATIONS; INVERSION OF CONFIGURATIONS; MITSUNOBU REACTIONS; NUCLEOBASE; NUCLEOBASES; SYNTHESIS OF;

SYNTHESIS (CHEMICAL);

(2 BENZYLOXY 3 TRITYLOXYMETHYLCYCLOPENT 1 YL) 4 NITROBENZOATE; (2 BENZYLOXY 3 TRITYLOXYMETHYLCYCLOPENTYLOXY)TERT BUTYLDIMETHYLSILANE; 1 (2 BENZYLOXY 3 HYDROMETHYLCYCLOPENTYL)URACIL; 1 (4 HYDROXYMETHYLCYCLOPENTAN 1 YL)THYMINE (6 CARBA 2,3 DIDEOXYTHYMIDINE); 2 BENZYLOXY 3 TRITYLOXYMETHYLCYCLOPENT 1 YL METHANESULFONATE; 2 BENZYLOXY 3 TRITYLOXYMETHYLCYCLOPENTAMINE; 2 BENZYLOXY 3 TRITYLOXYMETHYLCYCLOPENTAN 1 OL; 3 BENZOYL 1 (4 ACETOMETHYLCYCLOPENTAN 1 YL)THYMINE; 3 BENZOYL 1 (4 ACETOXYMETHYLCYCLOPENTAN 1 YL)THYMINE; 6 CARBA 2,3 DIDEOXY 6 HYDROXY LEVO URIDINE; ANTIVIRUS AGENT; ARISTEROMYCIN; CARBOCYCLIC THYMIDINE; ENTECAVIR; N (2 BENZYLOXY 3 TRITYLOXYMETHYLCYCLOPENT 1 YL)PHTHALIMIDE; N (2 BENZYLOXY 3 TRITYLOXYMETHYLCYCLOPENTYL) N (3 METHOXYACRYLOYL)UREA; NUCLEIC ACID BASE; NUCLEOPHILE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG; [(3 HYDROXYCYCLOPENT 1 YL)METHYL]ACETATE; [3 (TERT BUTYLDIMETHYLSILANYLOXYCYCLOPENT 1 YL)METHANYL]ACETATE; [3 (TERT BUTYLDIMETHYLSILYLOXY)CYCLOPENT 1 YL]METHANOL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; FURAN DERIVATIVE; NUCLEOTIDE;

ARTICLE; CHEMICAL MODIFICATION; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; MITSUNOBU REACTION; MUKAIYAMA REACTION; STEREOCHEMISTRY; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; ORGANIC CHEMISTRY; PROCEDURES; STEREOISOMERISM; SYNTHESIS;

ANTI-HIV AGENTS; CHEMISTRY, ORGANIC; CYCLIZATION; FURANS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; NUCLEOTIDES; STEREOISOMERISM;

EID: 57449097989     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo801848h     Document Type: Article

References (149)

1. (a) De Clercq, E. J. Clin. Vir. 2004, 30, 115-133.
2. (b) De Clercq, E. Nat. Rev. Drug Discov. 2002, 1, 13-25.
3. (a) Marquez, V. E. In Advances in Antiviral Drug Design; De Clercq, E., Ed.; JAI Press Inc.: 1996; Vol. 2, pp 89-145.
4. (a) Arjona, O.; Gómez, A. M.; López, J. C.; Plumet, J. Chem. Rev. 2007, 107, 1919-2036.
5. (b) Amblard, F.; Nolan, S. P.; Agrofoglio, L. A. Tetrahedron 2005, 61, 7067-7080.
6. (c) Paquette, L. A. Aust. J. Chem. 2004, 57, 7-17.
7. (d) Agrofoglio, L. A.; Gillaizeau, I.; Saito, Y. Chem. Rev. 2003, 103, 1875-1916.
8. (e) Rodríguez, J. B.; Comin, M. J. Mini Rev. Med. Chem. 2003, 3, 95-114.
9. (f) Schneller, S. W. Curr. Top. Med. Chem. 2002, 2, 1087-1092.
10. (g) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319-4347.
11. (h) Zhu, X.-F. Nucleosides Nucleotides Nucleic Acids 2000, 19, 651-690.
12. (i) Meldgaard, M.; Wengel, J. J. Chem. Soc., Perkin Trans. 1 2000, 3539-3554.
13. (j) Crimmins, M. T. Tetrahedron 1998, 54, 9229-9272.
14. (k) Agrofoglio, L.; Suhas, E.; Farese, A.; Condom, R.; Challand, S. R.; Earl, R. A.; Guedj, R. Tetrahedron 1994, 50, 10611-10670.
15. (l) Borthwick, A. D.; Biggadike, K. Tetrahedron 1992, 48, 571-623.
16. (m) Huryn, D. M.; Okabe, M. Chem. Rev. 1992, 92, 1745-1768.
17. (n) Marquez, V. E.; Lim, M.-I. Med. Res. Rev. 1986, 6, 1-40.
18. Kusaka, T.; Yamamoto, H.; Shibata, M.; Muroi, M.; Kishi, T.; Mizuno, K. J. Antibiot. 1968, 21, 255-263.
19. Yaginuma, S.; Muto, N.; Tsujino, M.; Sudate, Y.; Hayashi, M.; Otani, M. J. Antibiot. 1981, 34, 359-366.
20. Madhavan, G. V. B.; McGee, D. P. C.; Rydzewski, R. M.; Boehme, R.; Martin, J. C.; Prisbe, E. J. J. Med. Chem. 1988, 31, 1798-1804.
21. (a) Vince, R.; Hua, M.; Brownell, J.; Daluge, S.; Lee, F.; Shannon, W. M.; Lavelle, G. C.; Qualls, J.; Weislow, O. S.; Kiser, R.; Canonico, P. G.; Schultz, R. H.; Narayanan, V. L.; Mayo, J. G.; Shoemaker, R. H.; Boyd, M. R. Biochim. Biophys. Res. Commun. 1988, 156, 1046-1053.
22. (b) Vince, R.; Hua, M. J. Med. Chem. 1990, 33, 17-21.
23. (a) Daluge, S. M.; Good, S. S.; Faletto, M. B.; Miller, W. H.; St. Clair, M. H.; Boone, L. R.; Tisdale, M.; Parry, N. R.; Reardon, J. E.; Dornsife, R. E.; Averett, D. R.; Krenitsky, T. A. Antimicrob. Agents Chemother. 1997, 41, 1082-1093.
24. (b) Tisdale, M.; Alnadaf, T.; Cousens, D. Antimicrob. Agents Chemother. 1997, 41, 1094-1098.
25. (c) Faletto, M. B.; Miller, W. H.; Garvey, E. P.; St. Clair, M. H.; Daluge, S. M.; Good, S. S. Antimicrob. Agents Chemother. 1997, 41, 1099-1107.
26. (d) Hervey, P. S.; Perry, C. M. Drugs 2000, 60, 447-479.
27. (e) Crimmins, M. T.; King, B. W. J. Org. Chem. 1996, 61, 4192-4193.
28. (a) Katagiri, N.; Nomura, M.; Sato, H.; Kaneko, C.; Yusa, K.; Tsuruo, T. J. Med. Chem. 1992, 35, 1882-1886.
29. (b) Katagiri, N.; Toyota, A.; Shiraishi, T.; Sato, H.; Kaneko, C. Tetrahedron Lett. 1992, 33, 3507-3510.
30. Borthwick, A. D.; Kirk, B. E.; Biggadike, K.; Exall, A. M.; Butt, S.; Roberts, S. M.; Knight, D. J.; Coates, J. A. V.; Ryan, D. M. J. Med. Chem. 1991, 34, 907-914.
31. Bisacchi, G. S.; Chao, S. T.; Bachard, C.; Daris, J. P.; Innaimo, S.; Jacobs, G. A.; Kocy, O.; Lapointe, P.; Martel, A.; Merchant, Z.; Slusarchyk, W. A.; Sundeen, J. E.; Young, M. G.; Colonno, R.; Zahler, R. Bioorg. Med. Chem. Lett. 1997, 7, 127-132.
32. (a) Schreibman, I. R.; Schiff, E. R. Future Virol. 2006, 1, 541-552.
33. (b) Innaimo, S. F.; Seifer, M.; Bisacchi, G. S.; Standring, D. N.; Zahler, R.; Colonno, R. J. Antimicrob. Agents Chemother. 1997, 41, 1444-1448.
34. (c) Lai, C.-L.; Rosmawati, M.; Lao, J.; Van Vlierberghe, H.; Anderson, F. H.; Thomas, N.; DeHertogh, D. Gastroenterology 2002, 123, 1831-1838.
35. Example (Cyclobut-A): Norbeck, D. W.; Kern, E.; Hayashi, S.; Rosenbrook, W.; Sham, H.; Herrin, T.; Plattner, J. J.; Erickson, J.; Clement, J.; Swanson, R.; Shipkowitz, N.; Hardy, D.; Marsh, K.; Arnett, G.; Shannon, W.; Broder, S.; Mitsuya, H. J. Med. Chem. 1990, 33, 1281-1285.
36. (a) Wang, J.; Froeyen, M.; Hendrix, C.; Andrei, G.; Snoeck, R.; De Clercq, E.; Herdewijn, P. J. Med. Chem. 2000, 43, 736-745.
37. (b) Herdewijn, P.; De Clercq, E. Bioorg. Med. Chem. Lett. 2001, 11, 1591-1597.
38. (c) Barral, K.; Courcambeck, J.; Pèpe, G.; Balzarini, J.; Neyts, J.; De Clercq, E.; Camplo, M. J. Med. Chem. 2005, 48, 450-456.
39. Reviews (a) Moser, W. H. Tetrahedron 2001, 57, 2065-2084.
40. (b) Yus, M.; Nájera, C.; Foubelo, F. Tetrahedron 2003, 59, 6147-6212.
41. (c) Smith, A. B., III; Adams, C. M. Acc. Chem. Res. 2004, 37, 365-377.
42. (d) Schaumann, E.; Kirschning, A. Synlett 2007, 177-190.
43. (e) Kirschning, A.; Kujat, C.; Luiken, S.; Schaumann, E. Eur. J. Org. Chem. 2007, 2387-2400.
44. (a) Ley, S. V.; Anthony, N. J.; Armstrong, A.; Brasca, M. G.; Clarke, T.; Culshaw, D.; Greck, C.; Grice, P.; Jones, A. B.; Lygo, B.; Madin, A.; Sheppard, R. N.; Slawin, A. M. Z.; Williams, D. J. Tetrahedron 1989, 45, 7161-7194.
45. (b) Rychnovsky, S. D.; Griesgraber, G.; Powers, J. P. Org. Synth. 2000, 77, 1-11.
46. (c) Terauchi, T.; Terauchi, T.; Sato, I.; Tsukada, T.; Kanoh, N.; Nakata, M. Tetrahedron Lett. 2000, 41, 2649-2653.
47. (d) Boydell, A. J.; Jeffery, M. J.; Bürkstümmer, E.; Linclau, B. J. Org. Chem. 2003, 68, 8252-8255.
48. (a) Nakatsuka, M.; Ragan, J. A.; Sammakia, T.; Smith, D. B.; Uehling, D. E.; Schreiber, S. L. J. Am. Chem. Soc. 1990, 112, 5583-5601.
49. (b) Chenera, B.; Boehm, J. C.; Dreyer, G. B. Bioorg. Med. Chem. Lett. 1991, 1, 219-222.
50. (c) Dreyer, G. B.; Boehm, J. C.; Chenera, B.; DesJarlais, R. L.; Hassell, A. M.; Meek, T. D.; Tomaszek, T. A., Jr.; Lewis, M. Biochemistry 1993, 32, 937-947.
51. (d) Leung, L. M. H.; Gibson, V.; Linclau, B. Tetrahedron: Asymmetry 2005, 16, 2449-2453.
52. Leung, L. M. H.; Boydell, A. J.; Gibson, V.; Light, M. E.; Linclau, B. Org. Lett. 2005, 7, 5183-5186.
53. See Figure 1 and: (a) Lee, J. A.; Kim, H. O.; Tosh, D. K.; Moon, H. R.; Kim, S.; Jeong, L. S. Org. Lett. 2006, 8, 5081-5083.
54. (b) Roy, B. G.; Maity, J. K.; Drew, M. G. B.; Achari, B.; Mandal, S. B. Tetrahedron Lett. 2006, 47, 8821-8825.
55. (c) Banerjee, S.; Ghosh, S.; Sinha, S.; Ghosh, S. J. Org. Chem. 2005, 70, 4199-4202.
56. (d) Yin, X.-Q.; Schneller, S. W. Tetrahedron Lett. 2005, 46, 7535-7538.
57. (e) Takagi, C.; Sukeda, M.; Kim, H.-S.; Wataya, Y.; Yabe, S.; Kitade, Y.; Matsuda, A.; Shuto, S. Org. Biomol. Chem. 2005, 3, 1245-1251.
58. (f) Yang, Y.-Y.; Meng, W.D.; Qing, F.-L. Org. Lett. 2004, 6, 4257-4259.
59. (g) Ruediger, E.; Martel, A.; Meanwell, N.; Solomon, C.; Turmel, B. Tetrahedron Lett. 2004, 45, 739-742.
60. (h) Kim, J. W.; Choi, B. G.; Hong, J. H. Bull. Korean Chem. Soc. 2004, 25, 1812-1816.
61. (i) Hong, J. H.; Oh, C.-H.; Cho, J.-H. Tetrahedron 2003, 59, 6103-6108.
62. (j) Franzyk, H.; Jensen, S. R.; Olsen, C. E.; Rasmussen, J. H. Nucleosides Nucleotides Nucleic Acids 2002, 21, 23-43.
63. (k) Bianco, A.; Celletti, L.; Mazzei, R. A.; Umani, F. Eur. J. Org. Chem. 2001, 1331-1334.
64. (l) Roy, A.; Chakrabarty, K.; Dutta, P. K.; Bar, N. C.; Basu, N.; Achari, B.; Mandal, S. B. J. Org. Chem. 1999, 64, 2304-2309.
65. (m) Urata, H.; Miyagoshi, H.; Yumoto, T.; Akagi, M. J. Chem. Soc., Perkin Trans. 1 1999, 1833-1838.
66. (n) Urata, H.; Miyagoshi, H.; Kakuya, H.; Tokumoto, H.; Kawahata, T.; Otake, T.; Akagi, M. Chem. Pharm. Bull. 1998, 46, 458-461.
67. (o) Portmann, S.; Altmann, K.-H.; Reynes, N.; Egli, M. J. Am. Chem. Soc. 1997, 119, 2396-2403.
68. (p) Wachtmeister, J.; Classon, B.; Samuelsson, B. Tetrahedron 1997, 53, 1861-1872.
69. (q) Kraus, G. A.; Begey, T.; Wang, X. Nucleosides, Nucleotides Nucleic Acids 1997, 16, 1961-1965.
70. (r) Tanaka, M.; Norimine, Y.; Fujita, T.; Suemune, H. J. Org. Chem. 1996, 61, 6952-6957.
71. (s) Altmann, K.-H.; Kesselring, R.; Pieles, U. Tetrahedron 1996, 52, 12699-12722.
72. (t) Desai, D. H.; Cheikh, A. B.; Zemlicka, J. Tetrahedron Lett. 1991, 32, 6281-6284.
73. (u) Coe, D. M.; Parry, D. M.; Roberts, S. M.; Storer, R. J. Chem. Soc., Perkin Trans. 1 1991, 2373-2377.
74. (v) Cheikh, A. B.; Craine, L. E.; Recher, S. G.; Zemlicka, J. J. Org. Chem. 1988, 53, 929-936.
75. Examples: (a) Yin, X.-Q.; Schneller, S. W. Tetrahedron Lett. 2005, 46, 1927-1929.
76. (b) Biggadike, K.; Borthwick, A. D.; Exall, A. M. J. Chem. Soc., Chem. Commun. 1990, 458-459.
77. (a) Brook, A. G. Acc. Chem. Res. 1974, 7, 77-84.
78. (b) Jankowski, P.; Raubo, P.; Wicha, J. Synlett 1994, 985-992.
79. (c) Lautens, M.; Delanghe, P. H. M.; Goh, J. B.; Zhang, C. H. J. Org. Chem. 1995, 60, 4213-4227.
80. (a) Fischer, M.-R.; Kirschning, A.; Michel, T.; Schaumann, E. Angew. Chem., Int. Ed. Engl. 1994, 33, 217-218.
81. (b) Tietze, L. F.; Geissler, H.; Gewert, J. A.; Jakobi, U. Synlett 1994, 511-512.
82. (c) Plantier-Royon, R.; Portella, C. Synlett 1994, 527-529.
83. (a) Shinokubo, H.; Miura, K.; Oshima, K.; Utimoto, K. Tetrahedron Lett. 1993, 34, 1951-1954.
84. (b) Shinokubo, H.; Miura, K.; Oshima, K.; Utimoto, K. Tetrahedron 1996, 52, 503-514.
85. (c) Smith, A. B., III; Boldi, A. M. J. Am. Chem. Soc. 1997, 119, 6925-6926.
86. Smith, A. B., III; Pitram, S. M.; Boldi, A. M.; Gaunt, M. J.; Sfouggatakis, C.; Moser, W. H. J. Am. Chem. Soc. 2003, 125, 14435-14445, and references cited therein.
87. Smith, A. B., III; Xian, M. J. Am. Chem. Soc. 2006, 128, 66-67.
88. (a) Bräuer, N.; Dreessen, S.; Schaumann, E. Tetrahedron Lett. 1999, 40, 2921-2924.
89. See also: (b) Bouillon, J.-P.; Portella, C. Tetrahedron Lett. 1997, 38, 6595-6598.
90. (a) Le Merrer, Y.; Gravier-Pelletier, C.; Maton, W.; Numa, M.; Depezay, J.-C. Synlett 1999, 1322-1324.
91. (b) Gravier-Pelletier, C.; Maton, W.; Lecourt, T.; Le Merrer, Y. Tetrahedron Lett. 2001, 42, 4475-4478.
92. (c) Gravier-Pelletier, C.; Maton, W.; Dintinger, T.; Tellier, C.; Le Merrer, Y. Tetrahedron 2003, 59, 8705-8720.
93. (d) Gravier-Pelletier, C.; Maton, W.; Le Merrer, Y. Synlett. 2003, 333-336.
94. For nomenclature, see: (a) Narayan, R. S.; Sivakumar, M.; Bouhlel, E.; Borhan, B. Org. Lett. 2001, 3, 2489-2492, and references cited therein.
95. Jalce, G.; Franck, X.; Seon-Meniel, B.; Hocquemiller, R.; Figadère, B. Tetrahedron Lett. 2006, 47, 5905-5908.
96. Previous syntheses of 35: (a) Shealy, Y. F.; O'Dell, C. A.; Thorpe, M. C. J. Heterocycl. Chem. 1981, 18, 383-389.
97. (b) Hronowski, L. J. J.; Szarek, W. A. Can. J. Chem. 1988, 66, 61-70.
98. (c) Bères, G.; Sági, I.; Tömösközi, I.; Gruber, E.; Gulácsi, L.; Ötvös, L. Tetrahedron Lett. 1988, 29, 2681-2684.
99. (d) Baumgartner, H.; Bodenteich, M.; Griengl, H. Tetrahedron Lett. 1988, 29, 5745-5746.
100. (e) Wang, P.; Gullen, B.; Newton, M. G.; Cheng, Y.-C.; Schinazi, R. F.; Chu, C. K. J. Med. Chem. 1999, 42, 3390-3399.
101. (f) Ludek, O. R.; Baizarini, J.; Meier, C. Eur. J. Org. Chem. 2006, 932-940.
102. (a) Szarek, W. A.; Depew, C.; Jarrell, H. C.; Jones, J. K. N. J. Chem. Soc., Chem. Commun. 1975, 648-649.
103. (b) Iwakawa, M.; Pinto, B. M.; Szarek, W. A. Can. J. Chem. 1978, 56, 326-335.
104. (c) Marquez, V. E.; Tseng, C. K. H.; Treanor, S. P.; Driscoll, J. S. Nucleosides Nucleotides 1987, 6, 239-244.
105. (d) Bestmann, H. J.; Roth, D. Angew. Chem., Int. Ed. 1990, 29, 99-100.
106. (e) Jenny, T. F.; Previsani, N.; Benner, S. A. Tetrahedron Lett. 1991, 32, 7029-7032.
107. (f) Jenny, T. F.; Horlacher, J.; Previsani, N.; Benner, S. A. Helv. Chim. Acta 1992, 75, 1944-1954.
108. (a) Hauptmann, H.; Walter, W. F. Chem. Rev. 1961, 61, 347-404.
109. (b) Lipshutz, B. H.; Moretti, R.; Crow, R. Tetrahedron Lett. 1989, 30, 15-18.
110. (a) Cruickshank, K. A.; Jiricny, J.; Reese, C. B. Tetrahedron Lett. 1984, 25, 681-684.
111. (b) Frieden, M.; Giraud, M.; Reese, C. B.; Song, Q. J. Chem. Soc., Perkin Trans. 1 1998, 2827-2832.
112. (a) Mitsunobu, O. Synthesis 1981, 1-28.
113. (b) Hughes, D. L. In Organic reactions; Paquette, L. A., Ed.; John Wiley and Sons: New York, 1992; Vol. 42, pp 335-656.
114. (c) Dandapani, S.; Curran, D. P. Chem. - Eur. J. 2004, 10, 3130-3138.
115. (d) Dembinski, R. Eur. J. Org. Chem. 2004, 2763-2772.
116. (e) But, T. Y. S.; Toy, P. H. Chem. Asian J. 2007, 2, 1340-1355.
117. Examples: (a) Bonnal, C.; Chavis, C.; Lucas, M. J. Chem. Soc., Perkin Trans. 1 1994, 1401-1410.
118. (b) Borthwick, A. D.; Crame, A. J.; Exall, A. M.; Weingarten, G. G.; Mahmoudian, M. Tetrahedron Lett. 1995, 36, 6929-6932.
119. (c) Chong, Y.; Gumina, G.; Chu, C. K. Tetrahedron: Asymmetry 2000, 11, 4853-4875.
120. (d) Choo, H.; Chong, Y.; Chu, C. K. Org. Lett. 2001, 3, 1471-1473.
121. (e) Ludek, O. R.; Meier, C. Synthesis 2003, 2101-2109.
122. (f) Ludek, O. R.; Meier, C. Synlett 2005, 3145-3147.
123. (g) Ludek, O. R.; Meier, C. Eur. J. Org. Chem. 2006, 941-946.
124. (h) Ludek, O. R.; Krämer, T.; Balzarini, J.; Meier, C. Synthesis 2006, 1313-1324.
125. (i) Ludek, O. R.; Meier, C. Synlett 2006, 324-326,
126. See also: (j) Comins, D. L.; Jianhua, G. Tetrahedron Lett. 1994, 35, 2819-2822.
127. (a) Jones, M. F.; Roberts, S. M. J. Chem. Soc., Perkin Trans. 1 1988, 2927-2932.
128. (b) Gooding, H.; Roberts, S. M.; Storer, R. J. Chem. Soc., Perkin Trans. 1 1994, 1891-1892.
129. (c) Wang, P.; Agrofoglio, L. A.; Newton, M. G.; Chu, C. K. Tetrahedron Lett. 1997, 38, 4207-4210.
130. (d) Howarth, N. M.; Wakelin, L. P. G.; Walker, D. M. Tetrahedron Lett. 2003, 44, 695-698.
131. (e) Zhu, X.-F.; Nydegger, F.; Gossauer, A. Helv. Chim. Acta 2004, 87, 2245-2265.
132. (f) Hartung, R.; Paquette, L. A. J. Org. Chem. 2005, 70, 1597-1604.
133. (g) Hartung, R. E.; Paquette, L. A. Synthesis 2005, 3209-3218.
134. (a) Martin, S. F.; Dodge, J. A. Tetrahedron Lett. 1991, 32, 3017-3020.
135. (b) Hughes, D. L.; Reamer, R. A. J. Org. Chem. 1996, 61, 2967-2971.
136. (a) Mukaiyama, T.; Shintou, T.; Fukumoto, K. J. Am. Chem. Soc. 2003, 125, 10538-10539.
137. (b) Shintou, T.; Mukaiyama, T. Chem. Lett. 2003, 32, 984-985.
138. (c) Shintou, T.; Fukumoto, K.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2004, 77, 1569-1579.
139. (d) Shintou, T.; Mukaiyama, T. J. Am. Chem. Soc. 2004, 126, 7359-7367.
140. (e) Mukaiyama, T.; Ikegai, K.; Aoki, H.; Pluempanupat, W.; Masutani, K. Proc. Japan Acad., Ser. B 2005, 81, 103-109.
141. (f) Mukaiyama, T. Angew. Chem., Int. Ed. 2004, 43, 5590-5614.
142. Gonzàlez-Díaz, H.; Bonet, I.; Terán, C.; De Clercq, E.; Bello, R.; García, M. M.; Santana, L.; Uriarte, E. Eur. J. Med. Chem. 2007, 42, 580-585.
143. Acyl carbamate 55 was synthesized from (E)-methyl-3- methoxyacrylate in four steps: (a) Shaw, G.; Warrener, R. J. Chem. Soc. 1958, 153-156.
144. (b) Shaw, G.; Warrener, R. J. Chem. Soc. 1958, 157-161.
145. See also: (c) Tietze, L. F.; Schneider, C.; Pretor, M. Synthesis 1993, 1079-1080.
146. Wyatt, P. G.; Anslow, A. S.; Coomber, B. A.; Cousins, R. P. C.; Evans, D. N.; Gilbert, V. S.; Humber, D. C.; Paternoster, I. L.; Sollis, S. L.; Tapolczay, D. J.; Weingarten, G. G. Nucleosides Nucleotides 1995, 14, 2039-2049.
147. (a) Shealy, Y. F.; O'Dell, C. A. J. Heterocycl. Chem. 1976, 13, 1015-1020.
148. (b) Biggadike, K.; Borthwick, A. D.; Exall, A. M.; Kirk, B. E.; Roberts, S. M.; Youds, P.; Slawin, A. M. Z.; Williams, D. J. J. Chem. Soc., Chem. Commun. 1987, 255-256.
149. The United Kingdom Database Service: Fletcher, D. A., McMeeking, R. F., Parkin, D. J. Chem. Inf. Comput. Sci. 1996, 36, 746-749.